Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Testosterone cypionate - Pfizer

Next Previous
X
Search
Drug Profile

Testosterone cypionate - Pfizer

Alternative Names: Andro-Cyp-100; Andro-Cyp-200; Andronaq-LA; Andronate; D-Tes 100; depAndro 100; depAndro 200; Depo; Depo-Testosterone; Depotest; Depotest 100; Depotest 200; Depovirin; Dura-Testosterone; Duratest; Duratest-100; Malogen Cyp; Man-Agin; Meditest; Pertestis; Shotest; T-Cypionate; Testa-C; Testadiate-Depo; Testaspan; Testergon; Testex Leo Prolongatum; Testodrin; Testoject; Testoject-100 LA; Testosterone cyclopentanepropionate; Testosterone cypionate; Testred Cypionate 200

Latest Information Update: 08 Jan 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Andropause; Breast cancer; Breast disorders; Delayed puberty; Eunuchoidism; Hypogonadism; Oligospermia; Osteoporosis

Most Recent Events

  • 08 May 2020 Allergan has been acquired and merged into AbbVie
  • 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc
  • 04 Jan 2007 Schwarz Pharma has been acquired by UCB

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top